|
Sharkey, Robert M; Hajjar, George; Yeldell, Dion et al. (2005) A phase I trial combining high-dose 90Y-labeled humanized anti-CEA monoclonal antibody with doxorubicin and peripheral blood stem cell rescue in advanced medullary thyroid cancer. J Nucl Med 46:620-33
|
|
Blumenthal, Rosalyn D; Leone, Evelyn; Goldenberg, David M et al. (2004) An in vitro model to optimize dose scheduling of multimodal radioimmunotherapy and chemotherapy: effects of p53 expression. Int J Cancer 108:293-300
|
|
Blumenthal, R D; Leone, E; Goldenberg, D M (2003) Tumor-specific dose scheduling of bimodal radioimmunotherapy and chemotherapy. Anticancer Res 23:4613-9
|
|
Goldenberg, David M (2003) Advancing role of radiolabeled antibodies in the therapy of cancer. Cancer Immunol Immunother 52:281-96
|
|
Goldenberg, David M (2002) Targeted therapy of cancer with radiolabeled antibodies. J Nucl Med 43:693-713
|
|
Stein, Rhona; Chen, Susan; Reed, Linda et al. (2002) Combining radioimmunotherapy and chemotherapy for treatment of medullary thyroid carcinoma: effectiveness of dacarbazine. Cancer 94:51-61
|
|
Blumenthal, R D; Waskewich, C; Goldenberg, D M et al. (2001) Chronotherapy and chronotoxicity of the cyclooxygenase-2 inhibitor, celecoxib, in athymic mice bearing human breast cancer xenografts. Clin Cancer Res 7:3178-85
|
